New York, NY, United States of America

Calder Biosciences Inc.

USPTO Granted Patents = 5



Forward Citations = 33

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Christopher P Marshall (5 out of 9 patents)

silverMedal Peter Joseph Alff (2 out of 4 patents)

bronzeMedal Claudio Bertuccioli (2 out of 4 patents)

4.  Roberto Mariani (2 out of 17 patents)

5.  Nikolai Petrovsky (1 out of 8 patents)

6.  Mark Yondola (1 out of 3 patents)

7.  Sonal Gidwani (1 out of 3 patents)

8.  Mark Andrew Yondola (1 out of 2 patents)

9.  Kerry McGarr Empey (1 out of 1 patent)

10.  Jason Scott McLellan (1 out of 18 patents)

11.  Aaron Zomback (1 out of 1 patent)

12.  Christopher Patrick Marshall (0 patent)

13.  Jason Scott Mclellan (0 patent)

14.  Christopher Patrick Marshall (0 patent)

15.  Christopher Patrick Marshall (0 patent)


5 patents:

Company Overview
Calder Biosciences Inc. is a biotechnology company focused on developing innovative therapies for rare diseases. With a strong emphasis on research and development, Calder Biosciences is dedicated to improving the lives of patients through cutting-edge treatments. Our team of experts is committed to advancing scientific discoveries to address unmet medical needs in the rare disease space.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#1,193 in New York, NY

#3,133 in New York

#51,644 in US

New York, NY (US)
New York, NY, United States of America
Forward Citations = 33

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Calder Biosciences Inc.. Retrieved from https://idiyas.com/company/calder-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…